GlassScriptPhysician profile
Angela Knotts
NPI 1023550308
$508.18
in general payments reported to CMS, 2019-2025
12 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $53.75 · 2023: $43.91 · 2024: $79.05 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $205.16 | 2024-2025 | Evenity, Prolia, Uplizna |
| Lundbeck LLC | $55.77 | 2021-2022 | |
| Abbott Laboratories | $49.01 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.19 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $26.44 | 2025 | Ultomiris |
| Horizon Therapeutics Plc | $24.47 | 2023 | Krystexxa |
| Ucb, INC. | $21.26 | 2024 | Rystiggo |
| Gilead Sciences, INC. | $19.44 | 2023 | |
| Medtronic, INC. | $17.12 | 2025 | Synchromedii |
| Redhill Biopharma INC. | $15.55 | 2021 | |
| Allergan, INC. | $14.65 | 2021 | |
| Eisai INC. | $14.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Knotts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.